AC T10456
XX
ID T10456
XX
DT 18.05.2006 (created); kau.
DT 17.09.2015 (updated); sup.
CO Copyright (C), QIAGEN.
XX
FA p50
XX
OS human, Homo sapiens
OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates
XX
CL C0020; Rel.
XX
IN T08910 Bcl-3; human, Homo sapiens.
IN T00581 C/EBPbeta; human, Homo sapiens.
IN T08433 RXR-alpha; human, Homo sapiens.
XX
MX M03557 V$P50_Q6.
XX
BS R61153.
BS R32490.
BS R27918.
BS R37277.
BS R37279.
BS R30510.
BS R40311.
BS R63067.
BS R59335.
BS R59482.
BS R33333.
BS R33335.
BS R37622.
BS R37626.
BS R37631.
BS R60309.
BS R30672.
BS R31471.
BS R60319.
BS R21165.
BS R42005.
BS R35205.
BS R33636.
BS R33758.
BS R08088.
BS R40983.
BS R35058.
BS R34717.
BS R29952.
BS R66266.
BS R01634.
BS R30143.
BS R34823.
BS R60178.
BS R31357.
BS R39356.
BS R39357.
BS R37558.
BS R56352.
BS R56353.
BS R40146.
BS R56345.
BS R56346.
BS R36290.
BS R19783.
BS R30683.
BS R68249.
BS R68253.
BS R64968.
BS R24815.
BS R40952.
BS R11382.
BS R22506.
BS R22617.
BS R36880.
BS R66698.
BS R66699.
BS R66701.
BS R37632.
BS R37636.
BS R37640.
BS R39068.
BS R27891.
BS R34802.
BS R30537.
BS R34545.
BS R36026.
BS R36027.
BS R57945.
BS R57950.
BS R37951.
BS R69261.
BS R69262.
BS R42192.
BS R42194.
BS R42195.
BS R26907.
BS R59995.
BS R31476.
BS R37715.
BS R64783.
BS R32204.
BS R35547.
BS R41667.
BS R32902.
BS R39591.
BS R37847.
BS R01058.
BS R68096.
XX
DR TRANSPATH: MO000081695.
XX
RN [1]; RE0028144.
RX PUBMED: 10362352.
RA Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F. G., Scheidereit C., Leutz A.
RT The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
RL Oncogene 18:3316-23 (1999).
RN [2]; RE0047688.
RX PUBMED: 10075655.
RA Na S. Y., Kang B. Y., Chung S. W., Han S. J., Ma X., Trinchieri G., Im S. Y., Lee J. W., Kim T. S.
RT Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.
RL J. Biol. Chem. 274:7674-7680 (1999).
RN [3]; RE0047745.
RX PUBMED: 14673179.
RA Cohen S., Achbert-Weiner H., Ciechanover A.
RT Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.
RL Mol. Cell. Biol. 24:475-486 (2004).
RN [4]; RE0047755.
RX PUBMED: 16678126.
RA Cohen S., Lahav-Baratz S., Ciechanover A.
RT Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
RL Biochem. Biophys. Res. Commun. 345:7-13 (2006).
RN [5]; RE0048086.
RX PUBMED: 11526476.
RA Heppner C., Bilimoria K. Y., Agarwal S. K., Kester M., Whitty L. J., Guru S. C., Chandrasekharappa S. C., Collins F. S., Spiegel A. M., Marx S. J., Burns A. L.
RT The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.
RL Oncogene 20:4917-4925 (2001).
RN [6]; RE0051644.
RX PUBMED: 11239468.
RA Xiao G., Harhaj E. W., Sun S. C.
RT NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.
RL Mol. Cell 7:401-409 (2001).
RN [7]; RE0054190.
RX PUBMED: 12820969.
RA Saccani S., Pantano S., Natoli G.
RT Modulation of NF-kappaB activity by exchange of dimers.
RL Mol. Cell 11:1563-1574 (2003).
XX
//